The 62nd PTCOG Conference, themed "Synergy Through Collaboration," was held from June 10 to 15 at the Suntec Singapore Convention & Exhibition Centre. Over 1,200 experts and scholars from the particle therapy industry, representing 42 countries and regions, attended the event. The conference aimed to advance cooperation and collaboration in the field of particle therapy, promoting research, technology, and clinical applications related to particle therapy. More than 60 companies from the global particle therapy industry participated in this grand event. Hefei CAS Ion medical and Technical Devices Co., Ltd. (HFICM), the only Chinese manufacturer providing superconducting cyclotron proton system solutions, showcased its products at this academic conference and exhibition.

The academic conference featured in-depth discussions on cutting-edge technologies in particle therapy, including FLASH (Flash Radiotherapy), ARC (Arc Radiotherapy), SFRT (Spatially Fractionated Radiotherapy), and ART (Adaptive Radiotherapy).

HFCIM displayed its series of superconducting cyclotrons and next-generation compact proton therapy systems, which can be equipped with advanced international technologies such as FLASH, ARC, and CW. These exhibits drew significant attention from international experts and scholars, attracting numerous hospital specialists and potential clients for consultations and discussions. The team provided a comprehensive presentation of HFCIM proton therapy solutions, highlighting the key technologies of their cyclotrons and the clinical advantages of their applications.

PTCOG's 9th President Jay Flanz

HFCIM team is showing exhibits

HFCIM team is visiting NCCS Goh Cheng Liang Proton Therapy Center

Additionally, three academic posters from HFCIM were accepted and displayed at the conference. The posters covered topics such as the progress of Chinese-made superconducting proton therapy system in Hefei, a rapid CBCT image-guided algorithm based on real-time computed short scan weights, and the optimized design of the rotating gantry for the Hefei proton therapy system. These presentations provided an in-depth introduction to HFCIM's latest developments and significant technological innovations in the proton equipment field, fully demonstrating the strong capabilities in equipment research, development, and manufacturing of HFCIM.

HFCIM Academic Posters

As a leading manufacturer of high-end medical equipment in China, HFCIM is dedicated to providing more advanced, safe, and effective treatment solutions for cancer patients. HFCIM remains committed to technological innovation in the medical equipment industry and will continue to contribute to the advancement of cancer treatment.